Account-creators
1,040
edits
Difference between revisions of "Neurocytoma"
Jump to navigation
Jump to search
→IHC: update
Jensflorian (talk | contribs) (→Microscopic: +details) |
Jensflorian (talk | contribs) (→IHC: update) |
||
| Line 42: | Line 42: | ||
*Synaptophysin +ve. | *Synaptophysin +ve. | ||
**Most glial tumour -ve.<ref>URL: [http://path.upmc.edu/cases/case383/dx.html http://path.upmc.edu/cases/case383/dx.html]. Accessed on: 15 January 2012.</ref> | **Most glial tumour -ve.<ref>URL: [http://path.upmc.edu/cases/case383/dx.html http://path.upmc.edu/cases/case383/dx.html]. Accessed on: 15 January 2012.</ref> | ||
==Molecular== | |||
*FGFR1-TACC1 fusions common.<ref>{{Cite journal | last1 = Sievers | first1 = P. | last2 = Stichel | first2 = D. | last3 = Schrimpf | first3 = D. | last4 = Sahm | first4 = F. | last5 = Koelsche | first5 = C. | last6 = Reuss | first6 = DE. | last7 = Wefers | first7 = AK. | last8 = Reinhardt | first8 = A. | last9 = Huang | first9 = K. | title = FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. | journal = Acta Neuropathol | volume = | issue = | pages = | month = Jul | year = 2018 | doi = 10.1007/s00401-018-1882-3 | PMID = 29978331 }}</ref> | |||
==See also== | ==See also== | ||